Employing of Fe3O4/CuO/ZnO@MWCNT MNCs in the solvent-free synthesis of new cyanopyrroloazepine derivatives and investigation of biological activity
Crossref DOI link: https://doi.org/10.1007/s11030-021-10319-y
Published Online: 2021-12-03
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zare Davijani, Neda
Kia-Kojoori, Reza
Abdolmohammadi, Shahrzad
Sadegh-Samiei, Sepehr
Text and Data Mining valid from 2021-12-03
Version of Record valid from 2021-12-03
Article History
Received: 5 July 2021
Accepted: 7 September 2021
First Online: 3 December 2021
Declarations
:
: This manuscript has not any conflict of interest.